September 30, 2026- Abbott announced the U.S. commercial launch of SimpleScreen™ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease. Developed and manufactured by Freenome and exclusively commercialized by Abbott, SimpleScreen CRC joins the Cologuard Plus® test in Abbott's colorectal cancer … [Read more...]
Walgreens opens six new locations across the U.S.
September 30, 2026- Walgreens is celebrating the opening of six new Walgreens stores over the past few months, marking an exciting step forward in serving more communities. The company continues to evolve our store footprint in a flexible, market-by-market approach to best meet the needs of the communities we serve. Being the first choice for retail pharmacy remains central to … [Read more...]
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
September 30, 2026- Medtronic announced regulatory milestones for software used with two cardiac ablation platforms. This includes U.S. Food and Drug Administration (FDA) clearance and CE Mark for the latest Affera™ Prism-2 Mapping Software. The company also obtained CE Mark for the PulseSelect ProxBox™ Adapter with Proximity Indicator software. These milestones expand … [Read more...]
Henry Schein Cares marks 25 years of Helping Health Happen®
September 30, 2026- Henry Schein Cares, Henry Schein, Inc.’s global corporate citizenship program, is celebrating a quarter century of bringing together Team Schein Members, customers, supplier partners, healthcare professionals, nonprofit organizations, and communities to help make the world healthier. Today, Henry Schein Cares reflects the Company’s broader approach to … [Read more...]
Baxter releases inaugural Connected Hospital Report
September 30, 2026- Baxter International Inc. announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes. Based on a survey of 150 information technology (IT) and nursing leaders, the report examines how hospitals are … [Read more...]
Meeting the Moment: Navigating the complexities of supplying non-acute facilities
September 29, 2026- Supplying non-acute healthcare facilities presents a unique set of challenges. In a recent podcast with The Journal of Healthcare Contracting, Travis Miller, Vice President of Supply Chain Management Operations at Advocate Health (Midwest region), discussed the logistical and strategic nuances involved in supporting a growing network of non-acute care … [Read more...]
U.S. ban on $1 billion worth of Canadian imports goes into effect
September 29, 2026- The United States went ahead early Tuesday with a decision to ban nearly $1 billion worth of Canadian imports, including alcoholic beverages, dairy products and motorcycles, according to AP News. The latest began this summer when the U.S. imposed 50% tariffs on about $20 billion worth of Canadian imports, charging that Canada discriminates against U.S. … [Read more...]
SAMHSA grants nearly $250 million for behavioral health services
September 29, 2026- The Substance Abuse and Mental Health Services Administration Sept. 25 announced that it awarded $247.9 million in grants for services expanding access to addiction treatment, mental health services, and recovery support across the U.S. SAMHSA said the funds will support mental health services in schools, trauma treatment for children and families, efforts … [Read more...]
Teleflex Arrowg+ard™ technology demonstrates reduced CLABSI risk
September 29, 2026- Teleflex Incorporated announced the publication of its latest peer-reviewed study in the American Journal of Infection Control demonstrating that Central Venous Catheters (CVCs) protected with Arrowg+ard™ Technology were associated with a statistically significant 70% lower hazard of central line-associated bloodstream infections (CLABSIs) compared with … [Read more...]
Cepheid receives FDA Clearance for Xpert® Respiratory Panel
September 29, 2026- Cepheid announced that it has received FDA clearance for the Xpert Respiratory Panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab sample. The test is intended to aid in the diagnosis of individuals suspected of having respiratory tract infection with clinical signs and symptoms … [Read more...]









